Clin2
NCT07785388Possibly a fitNot yet recruiting

Genistein to protect heart health in HIV

HIVVascular DiseaseInflammationPain Management

Treatments studied

Part of Brain & nervous system, Heart & circulation clinical trials.

This study tests whether a daily supplement called genistein, derived from soy, can help reduce the risk of heart problems in people living with HIV. It aims to see if genistein can improve blood vessel function and lower inflammation, potentially protecting your heart.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
60 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are between 19 and 80 years old.
  • You are living with HIV and have a controlled viral load (undetectable) and a CD4 count of 350 or higher.
  • You do not have a history of heart disease.
  • You are not currently taking hormone replacement therapy or thyroid supplements.
  • You are not pregnant or breastfeeding.
  • You do not have certain conditions like cancer, liver or kidney problems, or uncontrolled diabetes.
  • You are not allergic to genistein or inulin.
  • You are willing to avoid soy products, genistein, isoflavonoids, and resveratrol during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06784154Recruiting
HIV and heart attack risk: a study on hidden body fat

This study looks at how hidden fat deep inside the body (ectopic fat) might increase heart attack risk in people living with HIV. By joining, you will help researchers understand this link and find better ways to protect your heart.

Liverpool
NCT07105007Recruiting
Heart health program for older adults living with HIV

This study tests a special program to help people living with HIV improve their heart health through activity and healthy habits. If you have early signs of heart trouble and are not currently very active, this support may help you feel better and reduce your risk.

Seattle, Washington
NCT05965518Recruiting
High-intensity exercise for brain and blood-vessel health in HIV

This trial tests whether high-intensity exercise can improve blood-vessel health and brain function in adults with HIV who are not very active and have thinking/memory problems. If you qualify, you’ll be asked to safely complete exercise and other study assessments.

Birmingham, Alabama
NCT07221214Recruiting· Phase 2
Testing a diabetes drug for drinking and heart health in HIV

This trial tests if a once-weekly diabetes medication (semaglutide) can help people with HIV reduce heavy drinking and improve heart health. It's for people who drink alcohol and have a higher body weight.

Nashville, Tennessee
NCT06634108Recruiting· Phase 1/Phase 2
Genistein for heart failure from ATTR amyloid cardiomyopathy

This trial tests whether genistein, a plant-based supplement, can help people with a specific type of heart disease called ATTR amyloid cardiomyopathy. You might join if you have heart failure with reduced pumping function and this rare protein condition.

London, Ontario
NCT06689566Recruiting
Genistein for heart attack recovery and inflammation

This study tests whether genistein, a natural compound found in soy, can help reduce inflammation and improve heart health in people who have had a heart attack and are overweight or have other risk factors.

Taipei, Taiwan

Hear when a new HIV trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.